Cardiovascular Research Applications BPC-157 has shown promising results in cardiovascular research, with studies demonstrating cardioprotective effects, blood pressure regulation, and enhanced angiogenesis (new blood vessel formation) in damaged tissues
Most side effects are mild, temporary, and manageable with proper dosage, quality products, and realistic expectations
Dosing & Reconstitution Guide Educational guide for reconstitution and daily dosing Standard / Gradual Approach (3 mL = ~1.67 mg/mL) Route: Subcutaneous | Frequency: Once daily Frequency: Inject once daily subcutaneously
Clinical trials demonstrate average weight loss of 10 to 15% of total body weight over 68 weeks at the 2.4 mg weekly dose
Thus, the observed bloom of Veillonella may represent a reactive microbiome adaptation to elevated systemic lactate and immune stress, rather than a stable feature associated with enhanced performance in broader athletic populations